Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients.
about
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's diseaseAzathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.Combined diosmectite and mesalazine treatment for mild-to-moderate ulcerative colitis: a randomized, placebo-controlled study.Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology.A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
P2860
Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of azathioprine or mesa ...... ecal Crohn's disease patients.
@en
Effect of azathioprine or mesa ...... ecal Crohn's disease patients.
@nl
type
label
Effect of azathioprine or mesa ...... ecal Crohn's disease patients.
@en
Effect of azathioprine or mesa ...... ecal Crohn's disease patients.
@nl
prefLabel
Effect of azathioprine or mesa ...... ecal Crohn's disease patients.
@en
Effect of azathioprine or mesa ...... ecal Crohn's disease patients.
@nl
P2093
P2860
P356
P1476
Effect of azathioprine or mesa ...... ecal Crohn's disease patients.
@en
P2093
Alexandre Zanini
Fernando Mendonça Vidigal
Fernando de Azevedo Lucca
Fábio Heleno de Lima Pace
Gláucio Silva de Souza
Julio Maria Fonseca Chebli
Karine Andrade de Oliveira Zanini
Leonardo Duque de Miranda Chaves
Liliana Andrade Chebli
Luiz Cláudio Ribeiro
P2860
P304
P356
10.12659/MSM.889196
P577
2013-08-30T00:00:00Z